HY Report - Increasing Sales Drives Revenue Growth

• Revenue of $2,418,713 highlights a 312% increase on the prior corresponding period (“PCP”) (H1 FY2021: $586,622) • Record result underpinned by strong, ongoing demand for medicinal cannabis for medicinal cannabis products • Loss after income tax $2,728,852 decreased by 10% on the PCP – despite significant increase in inventory and ongoing scale up of operations • Cash balance of $7,146,136 at th